CD274 and neoplasm: As the mAb B10G5 recognizes both sMIC and membrane-bound MIC as we have described previously [28], we thus sought to confirm that sMIC indeed negatively impacts tumor response to PD1/PD-L1 therapy, with a sMIC-expressing syngeneic tumor model (Additional file 1: Figure S2).